Authors
Loading...
Case report highlights how intravenous immunoglobulin can trigger myocardial infarction in high-risk patients, indicating need for caution.
Bose et al. (2026) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: